Detection of environmental mutagens using the FACIM assay
J Couteau1, J-M Flaman, C Minier
1LEMA, EA-3222, IFRMP 23, University of Le Havre, 76058 Le Havre cedex, France. jerome.couteau@univ-lehavre.fr
Marine Environmental Research
|April 19, 2008
Summary
A new yeast strain, FACIM II, detects environmental mutagens by measuring TP53 gene activity. This tool offers a sensitive and convenient method for environmental mutagen detection and mutation characterization.
Area of Science:
- Environmental Science
- Genetics
- Toxicology
Background:
- Environmental monitoring requires sensitive methods for detecting mutagens.
- Existing assays like SOS Chromotest have limitations in detecting direct-acting mutagens.
- The TP53 gene is a critical tumor suppressor, and its mutation is a key indicator of mutagenic activity.
Purpose of the Study:
- To develop and validate a genetically engineered yeast strain (yJC2) for environmental mutagen detection.
- To characterize the sensitivity and inducibility of the new assay (FACIM II) compared to existing methods.
- To assess the utility of FACIM II for detecting mutations induced by various mutagens.
Main Methods:
- Development of a diploid yeast strain (yJC2) with human TP53 gene and ADE2 reporter genes.
- Exposure of yJC2 cells to known mutagens (UVC, 4-nitroquinoline NQO) and environmental samples (Seine estuary sediment extract).
- Measurement of TP53 transcriptional activity and mutant frequency to assess mutagenic effects.
Main Results:
- The yJC2 strain demonstrated a significant, dose-dependent increase in mutant frequency upon exposure to UVC, NQO, and sediment extract.
- The FACIM II assay showed high sensitivity in detecting mutagenic activity in environmental samples.
- FACIM II proved more convenient and inducible than FACIM I and SOS Chromotest, respectively.
Conclusions:
- The FACIM II assay, utilizing the yJC2 yeast strain, is a powerful and convenient tool for environmental mutagen detection.
- This assay enables accurate measurement of TP53 transcriptional activity, serving as a reliable biomarker for mutagenicity.
- FACIM II offers an improved method for characterizing induced mutations and assessing environmental genotoxicity.
More Related Videos
Related Concept Videos
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.


